![Daniella Beckman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniella Beckman
Direktör/Styrelseledamot på
VOR BIOPHARMA INC.
Förmögenhet: 3 M $ per 2026-09-30
Profil
Daniella Beckman is Lead Independent Director at Vor Biopharma, Inc. since 2026 and Independent Director at Upstream Bio, Inc. since 2024.
Former roles include Independent Director at Blueprint Medicines Corp.
from 2021 to 2025, Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022, Independent Director at Translate Bio, Inc. from 2017 to 2021, Chief Financial Officer & PAO at Tango Therapeutics, Inc. from 2016 to 2026, Chief Financial Officer at BioNTech US, Inc. from 2015 to 2019, Chief Financial Officer at Beckman Consulting LLC from 2015 to 2019, CFO, Treasurer, Director & Vice President at Idenix Pharmaceuticals LLC from 2011 to 2014.
Education includes undergraduate studies at Boston University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
TANGO THERAPEUTICS, INC. 0,12 % | 2026-04-01 | 131 689 ( 0,12 % ) | 3 M $ | 2026-09-30 |
UPSTREAM BIO, INC. -.--% | 2026-06-09 | 0 ( -.--% ) | - $ | 2026-09-30 |
VOR BIOPHARMA, INC. -.--% | 2026-06-11 | 0 ( -.--% ) | - $ | 2026-09-30 |
Aktiva positioner av Daniella Beckman
| Företag | Position | Start |
|---|---|---|
| VOR BIOPHARMA INC. | Direktör/Styrelseledamot | 2020-07-16 |
| UPSTREAM BIO, INC. | Direktör/Styrelseledamot | 2024-10-11 |
Tidigare kända positioner av Daniella Beckman
| Företag | Position | Slut |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Finansdirektör/CFO | 2026-04-15 |
| BLUEPRINT MEDICINES CORPORATION | Direktör/Styrelseledamot | 2025-07-17 |
| 501 ACQU | Direktör/Styrelseledamot | 2022-01-01 |
| TRANSLATE BIO, INC. | Direktör/Styrelseledamot | 2021-09-14 |
| NEON THERAPEUTICS, INC. | Finansdirektör/CFO | 2019-09-01 |
Daniella Beckmans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
58
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and other infectious diseases caused by hepatitis and human immunodeficiency virus | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Beckman Consulting LLC
 Beckman Consulting LLC Miscellaneous Commercial ServicesCommercial Services Engages in the provision of consulting services | Commercial Services |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
